Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12031-021-01817-7.pdf
Reference45 articles.
1. Adamski V, Schmitt A, Flüh C, Synowitz M, Hattermann K, Held-Feindt J (2017) Isolation and characterization of fast-migrating human glioma cells in the progression of malignant gliomas. Oncol Res 25:341–353. https://doi.org/10.3727/096504016x14737243054982
2. Akyerli C et al (2018) Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas. J Neurosurg 128:1102–1114. https://doi.org/10.3171/2016.11.Jns16973
3. Borromeo M et al (2016) ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs. Cell Rep 16:1259–1272. https://doi.org/10.1016/j.celrep.2016.06.081
4. Chen X et al (2020) Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth. J Immunother Cancer 8. https://doi.org/10.1136/jitc-2020-000785
5. Cooper L et al (2010) The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PloS One 5:e12548. https://doi.org/10.1371/journal.pone.0012548
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses;BMC Cancer;2024-05-21
2. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma;Small;2023-08-30
3. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas;International Immunopharmacology;2023-04
4. Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients;Pakistan Journal of Medical Sciences;2023-03-28
5. Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma;International Journal of Molecular Sciences;2022-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3